Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters

Database
Language
Publication year range
1.
J Neuroimmunol ; 355: 577549, 2021 06 15.
Article in English | MEDLINE | ID: mdl-33839521

ABSTRACT

The pathophysiology of neurological diseases related to potassium-channel dysfunction such as epilepsy is increasingly linked to immune system modulation. However, there are limited reports of which interleukin-4 (IL-4) can act on the neuroinflammatory response after seizure. Hence, we evaluated the effect of IL-4 in murine model of neuroexcitotoxcity using kaliotoxin (KTx), a potassium-channel blocker. Results showed that IL-4 treatment can significantly reduce the neuronal death induced by KTx. Probably by decreasing mitochondria swelling, reversing oxidative damage and enhancing Bcl-2 expression. Furthermore, IL-4 treatment significantly reduced TNF-α expression and enhanced GFAP and IL-10 expressions in the brain. IL-4 can be neuroprotective in epileptogenesis.


Subject(s)
Cerebral Cortex/drug effects , Epilepsy/prevention & control , Immunologic Factors/administration & dosage , Interleukin-4/administration & dosage , Neuroprotective Agents/administration & dosage , Potassium Channel Blockers/toxicity , Animals , Cerebral Cortex/immunology , Cerebral Cortex/pathology , Epilepsy/chemically induced , Epilepsy/immunology , Epilepsy/pathology , Injections, Intraperitoneal , Injections, Intraventricular , Mice , Scorpion Venoms/toxicity
SELECTION OF CITATIONS
SEARCH DETAIL